These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32631352)

  • 1. The association of dietary patterns with endocannabinoids levels in overweight and obese women.
    Yagin NL; Hajjarzadeh S; Aliasgharzadeh S; Aliasgari F; Mahdavi R
    Lipids Health Dis; 2020 Jul; 19(1):161. PubMed ID: 32631352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma endocannabinoid levels in lean, overweight, and obese humans: relationships to intestinal permeability markers, inflammation, and incretin secretion.
    Little TJ; Cvijanovic N; DiPatrizio NV; Argueta DA; Rayner CK; Feinle-Bisset C; Young RL
    Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E489-E495. PubMed ID: 29438631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of endocannabinoids levels, FAAH gene polymorphisms, and appetite regulatory substances in women with and without binge eating disorder: a cross- sectional study.
    Yagin NL; Aliasgari F; Alizadeh M; Aliasgharzadeh S; Mahdavi R
    Nutr Res; 2020 Nov; 83():86-93. PubMed ID: 33038759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity.
    Monteleone AM; Di Marzo V; Monteleone P; Dalle Grave R; Aveta T; Ghoch ME; Piscitelli F; Volpe U; Calugi S; Maj M
    Eur J Nutr; 2016 Jun; 55(4):1799-805. PubMed ID: 26759262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity.
    Gatta-Cherifi B; Matias I; Vallée M; Tabarin A; Marsicano G; Piazza PV; Cota D
    Int J Obes (Lond); 2012 Jun; 36(6):880-5. PubMed ID: 21844878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary fatty acid intake and gut microbiota determine circulating endocannabinoidome signaling beyond the effect of body fat.
    Castonguay-Paradis S; Lacroix S; Rochefort G; Parent L; Perron J; Martin C; Lamarche B; Raymond F; Flamand N; Di Marzo V; Veilleux A
    Sci Rep; 2020 Sep; 10(1):15975. PubMed ID: 32994521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of endocannabinoids are independently associated with nonalcoholic fatty liver disease.
    Zelber-Sagi S; Azar S; Nemirovski A; Webb M; Halpern Z; Shibolet O; Tam J
    Obesity (Silver Spring); 2017 Jan; 25(1):94-101. PubMed ID: 27863097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin levels are negatively correlated with 2-arachidonoylglycerol in the cerebrospinal fluid of patients with osteoarthritis.
    Nicholson J; Azim S; Rebecchi MJ; Galbavy W; Feng T; Reinsel R; Rizwan S; Fowler CJ; Benveniste H; Kaczocha M
    PLoS One; 2015; 10(4):e0123132. PubMed ID: 25835291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating levels of endocannabinoids respond acutely to voluntary exercise, are altered in mice selectively bred for high voluntary wheel running, and differ between the sexes.
    Thompson Z; Argueta D; Garland T; DiPatrizio N
    Physiol Behav; 2017 Mar; 170():141-150. PubMed ID: 28017680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between sex, APOE genotype, endocannabinoids and cognitive change in older adults with metabolic syndrome during a 3-year Mediterranean diet intervention.
    Soldevila-Domenech N; Fagundo B; Cuenca-Royo A; Forcano L; Gomis-González M; Boronat A; Pastor A; Castañer O; Zomeño MD; Goday A; Dierssen M; Baghizadeh Hosseini K; Ros E; Corella D; Martínez-González MÁ; Salas-Salvadó J; Fernández-Aranda F; Fitó M; de la Torre R
    Nutr J; 2024 Jun; 23(1):61. PubMed ID: 38862960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating endocannabinoids in insulin sensitive vs. insulin resistant obese postmenopausal women. A MONET group study.
    Abdulnour J; Yasari S; Rabasa-Lhoret R; Faraj M; Petrosino S; Piscitelli F; Prud' Homme D; Di Marzo V
    Obesity (Silver Spring); 2014 Jan; 22(1):211-6. PubMed ID: 23616305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of circulating endocannabinoids with appetite regulatory substances in obese women.
    Lotfi Yagin N; Aliasgharzadeh S; Alizadeh M; Aliasgari F; Mahdavi R
    Obes Res Clin Pract; 2020; 14(4):321-325. PubMed ID: 32580926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caloric restriction lowers endocannabinoid tonus and improves cardiac function in type 2 diabetes.
    van Eyk HJ; van Schinkel LD; Kantae V; Dronkers CEA; Westenberg JJM; de Roos A; Lamb HJ; Jukema JW; Harms AC; Hankemeier T; van der Stelt M; Jazet IM; Rensen PCN; Smit JWA
    Nutr Diabetes; 2018 Jan; 8(1):6. PubMed ID: 29343706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-fat yogurt consumption reduces biomarkers of chronic inflammation and inhibits markers of endotoxin exposure in healthy premenopausal women: a randomised controlled trial.
    Pei R; DiMarco DM; Putt KK; Martin DA; Gu Q; Chitchumroonchokchai C; White HM; Scarlett CO; Bruno RS; Bolling BW
    Br J Nutr; 2017 Dec; 118(12):1043-1051. PubMed ID: 29179781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Endocannabinoids and Insulin Resistance in Patients with Obstructive Sleep Apnea.
    Wang X; Yu Q; Yue H; Zhang J; Zeng S; Cui F
    Biomed Res Int; 2016; 2016():9782031. PubMed ID: 26904688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Role for Peripheral Anandamide and 2-Arachidonoylglycerol in Short-Term Food Intake and Orexigenic Hypothalamic Responses in a Species with Continuous Nutrient Delivery.
    van Ackern I; Kuhla A; Kuhla B
    Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocannabinoids concentrations in plasma associated with feed efficiency and carcass composition of beef steers.
    Artegoitia VM; Foote AP; Lewis RM; King DA; Shackelford SD; Wheeler TL; Freetly HC
    J Anim Sci; 2016 Dec; 94(12):5177-5181. PubMed ID: 28046144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Endocannabinoids and Mortality in Hemodialysis Patients.
    Moradi H; Park C; Streja E; Argueta DA; DiPatrizio NV; You AS; Rhee CM; Vaziri ND; Kalantar-Zadeh K; Piomelli D
    Am J Nephrol; 2020; 51(2):86-95. PubMed ID: 31935741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocannabinoid crosstalk between placenta and maternal fat in a baboon model (Papio spp.) of obesity.
    Brocato B; Zoerner AA; Janjetovic Z; Skobowiat C; Gupta S; Moore BM; Slominski A; Zhang J; Schenone M; Phinehas R; Ferry RJ; Dick E; Hubbard GB; Mari G; Schlabritz-Loutsevitch N
    Placenta; 2013 Nov; 34(11):983-9. PubMed ID: 24008071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whey protein supplementation reducing fasting levels of anandamide and 2-AG without weight loss in pre-menopausal women with obesity on a weight-loss diet.
    Haidari F; Aghamohammadi V; Mohammadshahi M; Ahmadi-Angali K; Asghari-Jafarabadi M
    Trials; 2020 Jul; 21(1):657. PubMed ID: 32680548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.